Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

BACKGROUND: Whereas severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody tests are increasingly being used to estimate the prevalence of SARS-CoV-2 infection, the determinants of these antibody responses remain unclear. OBJECTIVES: Our aim was to evaluate systemic and mucos...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervia, Carlo, Nilsson, Jakob, Zurbuchen, Yves, Valaperti, Alan, Schreiner, Jens, Wolfensberger, Aline, Raeber, Miro E., Adamo, Sarah, Weigang, Sebastian, Emmenegger, Marc, Hasler, Sara, Bosshard, Philipp P., De Cecco, Elena, Bächli, Esther, Rudiger, Alain, Stüssi-Helbling, Melina, Huber, Lars C., Zinkernagel, Annelies S., Schaer, Dominik J., Aguzzi, Adriano, Kochs, Georg, Held, Ulrike, Probst-Müller, Elsbeth, Rampini, Silvana K., Boyman, Onur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677074/
https://www.ncbi.nlm.nih.gov/pubmed/33221383
http://dx.doi.org/10.1016/j.jaci.2020.10.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677074/
https://www.ncbi.nlm.nih.gov/pubmed/33221383
http://dx.doi.org/10.1016/j.jaci.2020.10.040

Ejemplares similares